Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far and remember, there are only a few more days until the weekend arrives. So keep plugging away. Meanwhile, we are coping with especially chilly winds whipsawing the Pharmalot campus by — yes, you guessed it — brewing a few cups of stimulation. Our choice today is cinnamon dolce. Yum. And now, time to get cracking. Here are a few items of interest to help you on your journey today. Hope you have a smashing time and do keep in touch.

A growing percentage of adults did not have enough money to pay for prescription medicines over the past year and only a fraction of Americans believe President Trump is doing enough to lower drug costs, which is a key campaign issue for him, STAT writes, citing a poll. Nearly 23% reported they lacked the funds this past September to pay for a prescription during the previous 12 months, up from 18.9% in January. All totaled, about 58 million adults experienced “medication insecurity.” Just 7% say Trump has made any progress lowering costs.

Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

Your daily dose of news in health and medicine

Privacy Policy